Galveston County Health District

Audits
3
Findings
41
Total Expended
$28.59M
Latest Accepted
2026-02-02
Location: Texas City, TX
UEI: SK8BQZM1Z5P5 EIN: 760521474

SAM.gov Exclusion Status:

Checking exclusion status...

Audits by Year

  • 2022 1
  • 2023 1
  • 2024 1

Top Programs

By expenditures

Loading recommendations...

Contacts

Name Title Type
Ruth Cable Chief Financial Officer Auditee
Godwin Okoye Partner Auditee
Latricia Bailey CHIEF FINANCIAL OFFICER Auditee
Chuck Kozlik Auditor Partner Auditee
No contacts on file

Recent Audits

ID Year Date Accepted Auditor Spend
385024 2024 2026-02-02 HAM LANGSTON & BREZINA LLP $8.52M
363352 2023 2025-07-30 McConnell Jones $10.73M
25112 2022 2023-06-29 Bankole Okoye & Associates PC $9.34M

Audit Findings

Audit Year Accepted Finding Ref Severity Repeat Requirement
385024 2024 2026-02-02 1171960 2024-005 Material Weakness Yes E
385024 2024 2026-02-02 1171959 2024-003 Material Weakness Yes B
385024 2024 2026-02-02 1171958 2024-002 Material Weakness Yes H
385024 2024 2026-02-02 1171957 2024-003 Material Weakness Yes B
385024 2024 2026-02-02 1171956 2024-002 Material Weakness Yes H
385024 2024 2026-02-02 1171955 2024-003 Material Weakness Yes B
385024 2024 2026-02-02 1171954 2024-002 Material Weakness Yes H
385024 2024 2026-02-02 1171953 2024-003 Material Weakness Yes B
385024 2024 2026-02-02 1171952 2024-002 Material Weakness Yes H
385024 2024 2026-02-02 1171951 2024-003 Material Weakness Yes B
385024 2024 2026-02-02 1171950 2024-002 Material Weakness Yes H
385024 2024 2026-02-02 1171949 2024-003 Material Weakness Yes B
385024 2024 2026-02-02 1171948 2024-002 Material Weakness Yes H
385024 2024 2026-02-02 1171947 2024-004 Material Weakness Yes N
385024 2024 2026-02-02 1171946 2024-002 Material Weakness Yes H
385024 2024 2026-02-02 1171945 2024-004 Material Weakness Yes N
385024 2024 2026-02-02 1171944 2024-002 Material Weakness Yes H
363352 2023 2025-07-30 1148666 2023-004 Significant Deficiency - C
363352 2023 2025-07-30 1148665 2023-004 Significant Deficiency - C
363352 2023 2025-07-30 1148664 2023-004 Significant Deficiency - C
363352 2023 2025-07-30 1148663 2023-004 Significant Deficiency - C
363352 2023 2025-07-30 1148662 2023-003 Significant Deficiency - L
363352 2023 2025-07-30 1148661 2023-003 Significant Deficiency - L
363352 2023 2025-07-30 1148660 2023-003 Significant Deficiency - L
363352 2023 2025-07-30 1148659 2023-003 Significant Deficiency - L
363352 2023 2025-07-30 1148658 2023-002 Material Weakness - N
363352 2023 2025-07-30 1148657 2023-002 Material Weakness - N
363352 2023 2025-07-30 1148656 2023-002 Material Weakness - N
363352 2023 2025-07-30 1148655 2023-002 Material Weakness - N
363352 2023 2025-07-30 572224 2023-004 Significant Deficiency - C
363352 2023 2025-07-30 572223 2023-004 Significant Deficiency - C
363352 2023 2025-07-30 572222 2023-004 Significant Deficiency - C
363352 2023 2025-07-30 572221 2023-004 Significant Deficiency - C
363352 2023 2025-07-30 572220 2023-003 Significant Deficiency - L
363352 2023 2025-07-30 572219 2023-003 Significant Deficiency - L
363352 2023 2025-07-30 572218 2023-003 Significant Deficiency - L
363352 2023 2025-07-30 572217 2023-003 Significant Deficiency - L
363352 2023 2025-07-30 572216 2023-002 Material Weakness - N
363352 2023 2025-07-30 572215 2023-002 Material Weakness - N
363352 2023 2025-07-30 572214 2023-002 Material Weakness - N
363352 2023 2025-07-30 572213 2023-002 Material Weakness - N